Research Project
Measures for Improved Availability of medicines and vaccines (MIA)
Ensuring availability of essential medicines, vaccines and health commodities is one of today鈥檚 critical societal challenges
2025
-
Jahre, M. and Walter A-B.
Farmasøyten som brobygger i forsyningskjeder for legemidler
Accepted for publication in Norsk Farmaceutisk Tidsskrift
-
Årdal, C., Gawad, M., Baraldi, E., Jahre, M. and Edlund, C.
Fragmented markets for older and paediatric antibiotics, Denmark, Norway, Sweden
Bulletin of the World Health Organization; Type: Policy & practice Article ID: BLT.24.292102
2024
-
Dube, N., Selviaridis, K., Van Oorschot, K., and Jahre, M.
Riding the waves of risk and opportunity in uncertain times: Towards strategic agility for medicine supply systems
Journal of Operations Management, DOI: 10.1002/joom.1330
-
Melaku, T., Mekonnen, Z., Terefe Tucho, G., Mecha, M., Årdal, C. and Jahre, M.
Availability of essential, generic medicines before and during COVID-19 at selected public pharmaceutical supply agencies in Ethiopia: a comparative cross-sectional study
BMJ Open, doi:10.1136/bmjopen-2023-077545
-
De Vries, H., Lemmens, S., Breugem, T., Olivier, M.
Impact Pathways: Improving Medicine Access Through Cross-National Stockpiling
International Journal of and Production Management, 44(13), 364-372
-
Melaku, T., Mekonnen, Z., Terefe Tucho, G., Mecha, M., Årdal, C. and Jahre, M.
Systems perspective on paracetamol products shortages: Resilience, adaptability, and challenges amidst the COVID-19 pandemic in Ethiopia
Logistics
2023
-
Brekke, K.R., D.M. Dalen and O.R.
Competing with Precision: Incentives for Developing Predictive Biomarker
Tests SSRN, Scandinavian Journal of Economics
-
Årdal, C.
«Forsker tror at flere tiltak er nødvendig for å sikre tilgang på eldre antibiotika»
Dagens Medisin, 14 September 2023.
-
Dalen, D.M.
Blåreseptanbud – også i praksis må legemiddelutgiftene finansieres.
Altinget.no, 4 August 2023
-
Brekke, K.R., D.M. Dalen and O.R. Straume
The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets.
Journal of Health Economics. July. Vol 90.
-
Dalen, D.M.
Anbud truer ikke velferdsstaten.
Altinget.no. 5 July 2023
-
Jahre, M. and Rasmussen, J.
Supply Chain Risk Management: Vær beredt for den nye (u)normalen, Praktisk Økonomi og Finans
Praktisk Økonomi og Finans
-
Zeleke Mekonnen, Tsegaye Melaku, Gudina Terefe Tucho, Mohammed Mecha, Christine Årdal and Marianne Jahre
BMC Health Services Research
-
Årdal, C.
Revive
-
Christine Årdal
Viewpoint
-
Brekke, K.R., D.M. Dalen and O.R. Straume
Competing with Precision: Incentives for Developing Predictive Biomarker Tests SSRN
Scandinavian Journal of Economics
-
Årdal, C.
Revive
-
Brekke, K.R., D.M. Dalen and O.R. Straume
The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets
Journal of Health Economics. July. Vol 90
-
Bygballe, L., Dubois, A. and Jahre, M.
Journal of Business Research, 154, 113333
-
Mekonnen, Z., Melaku, T., Terefe Tucho, G., Mecha, M., Årdal C. and Jahre, M.
BMC Health Services Research (2023) 23:513
2022
-
Kostas Selviaridis and Nonhlanhla Dube
The Conversation
-
Adilo, T.M., Zegeye, S., Demie, T.G. and Dinka, R.G.
Risk Management and Healthcare Policy
-
Kurt R. Brekke, Dag Morten Dalen, Odd Rune Straume
Scandinavian Journal of Economics
-
Oorschot, K.E. van, Van Wassenhove, L., Jahre, M., Selviaridis, K., Vries, H. de.
Decision Sciences
-
Victoria Ahlqvist, Nonhlanhla Dube, Marianne Jahre, Jin Soo Lee, Tsegaye Melaku, Andreas Farstad Moe, Max Olivier, Kostas Selviaridis, Joe Viana, Christine Aardal
International Journal of Physical Distribution & Logistics Management, available online September 28, 2022
-
Dube, N., Van Wassenhove, L. N., & van der Vaart, T.
Earmarked funding: Four reasons why we shouldn’t dictate where our charitable donations go
LSE British Politics and Policy
-
Dalen, D.M.
Dagens Medisin
-
Knight, L., Tate, W., Carnovale, S., Di Mauro, C., Bals, L., Caniato, F., Gualandris, J., Johnsen, T., Matopoulos, A., Meehan, J., Miemczyk, J., Patrucco, A., Schoenherr, T., Selviaridis, K., Touboulic, A. & Wagner, S.
Journal of Purchasing and Supply Management
-
Saïah, F., Vega, D., de Vries, H., & Kembro, J.
Production and operations management
-
Dube, N., Li, Q., Selviaridis, K., Jahre, M.
Journal of Purchasing and Supply Management
-
Oorschot, K.E. van, Van Wassenhove, L., Jahre, M.
Production and Operations Management.
Testing for COVID-19 is a key intervention that supports tracking and isolation to prevent further infections. However, diagnostic tests are a scarce and finite resource, so abundance in one country can quickly lead to shortages in others, creating a competitive landscape. Countries experience peaks in infections at different times, meaning that the need for diagnostic tests also peaks at different moments. This phase lag implies opportunities for a more collaborative approach, although countries might also worry about the risks of future shortages if they help others by reallocating their excess inventory of diagnostic tests. This article features a simulation model that connects three subsystems: COVID-19 transmission, the diagnostic test supply chain, and public policy interventions aimed at flattening the infection curve.
-
Brekke, K.R., Dalen, D.M. and Straume, O.R
Journal of Health Economics, 83, 102613
Two-part pricing (the Netflix model) has recently been proposed instead of uniform pricing for pharmaceuticals. Under two-part pricing the health plan pays a fixed fee for access to a drug at unit prices equal to marginal costs. Despite two-part pricing being socially efficient, we show that the health plan is worse off when the drug producer is a monopolist, as all surplus is extracted. This result is reversed with competition, as two-part pricing yields higher patient utility and lower drug costs for the health plan. However, if we allow for exclusive contracts, uniform pricing is preferred by the health plan. The choice of payment scheme is also shown to influence on the incentives to spend resources on drastic innovations relative to incremental, me-too innovations.
-
Adilo, T.M., Zegeye, S., Demie, T.G. and Dinka, R.G.
The Impact of COVID-19 on supplies of routine childhood immunization in Oromia regional state, Ethiopia: A mixed method study
Risk Management and Healthcare Policy,15, p. 2343–2355. (8997/0.556)
-
Brekke, K.R., Dalen, D.M. and Straume, O.R.
Paying for pharmaceuticals: uniform pricing versus two-part tariffs
Journal of Health Economics, 83, 102613
-
Ahlqvist, V., Dube, N., Jahre, M., Melaku, T., Moe, A., Olivier, M., Selviaridis, K., Viana, J. and Årdal, C.
Supply chain risk management strategies in normal and abnormal times: Policymakers’ role in reducing generic medicine shortages
International Journal of Physical Distribution and Logistics Management, 53(2), pp. 206-230, DOI 10.1108/IJPDLM-12-2021-0511
-
Dube, N., Li, Q., Selviaridis, K., Jahre, M.
Journal of Purchasing and Supply Management
-
Frennesson, L., Kembro, J., de Vries, H. Jahre, M. and Van Wassenhove, L.
International, Journal of Disaster Risk Reduction, 103410
-
Gartner, D., Viana, J., Rostami-Tabar, B., Edenharter, G. and Pförringer, D.
Challenging the Throwaway Culture in Hospitals: Scheduling the Mix of Reusable and Single-Use Bronchoscopes
Journal of the Operational Research Society
-
Knight, L., Tate, W., Carnovale, S., Di Mauro, C., Bals, L., Caniato, F., Gualandris, J., Johnsen, T., Matopoulos, A., Meehan, J., Miemczyk, J., Patrucco, A., Schoenherr, T., Selviaridis, K., Touboulic, A. & Wagner, S.
Future business and the role of purchasing and supply management: Opportunities for «business-not-as-usual» PSM research
Journal of Purchasing and Supply Management, 100573
-
Oorschot, K.E. van, Van Wassenhove, L., Jahre, M.
Production and Operations Management
-
Oorschot, K.E. van, Van Wassenhove, L., Jahre, M., Selviaridis, K., Vries, H. de.
Decision Sciences, 3 (6), pp. 969-984
-
Saïah, F., Vega, D., de Vries, H., & Kembro, J.
Production and operations management
2021
-
Dalen, M.
BI Business Review
-
Jahre, M., Årdal, C.
Dagens Næringsliv, Reprint in ‘Overlegen’
-
de Vries, H. Jahre, M., Selviaridis, K., van Oorschot, K. and Van Wassenhove, L.N.
International Journal of Operations and Production Management
This “impact pathways” paper argues that operations and supply chain management (OSCM) could help address the worsening drug shortage problem in high-income countries. This significant societal problem poses difficult challenges to stakeholders given the complex and dynamic nature of drug supply chains.
-
Viana, J., Van Oorschot, K., Årdal, C.
2021 Winter Simulation Conference Proceedings
The objective of the proposed hybrid simulation modeling framework is to improve the understanding and operation of medicine supply chains, to strengthen their resilience to ensure the availability of medicines. The framework draws upon hybrid simulation, supply chain resilience and medicine supply chain literature. The utility of the proposed framework is presented through the development of a case model of a generic (off-patent) case medicine in the 黑料专区 system to perform scenario-based experiments on disruption events and interventions.
-
Dalen, M.
Vaksinespillet
Dagens Medisin
-
De Vries, H. Jahre, M., Selviaridis, K., van Oorschot, K. and Van Wassenhove, L.N.
Short of Drugs? Call Upon Operations and Supply Chain Management
International Journal of Operations and Production Management, DOI (10.1108/IJOPM-03-2021-0175).
2020
-
Dalen, D.M.
Patenter når epidemiene rammer
Dagens Medisin
-
Ahlqvist, V., Norrman, A. and Jahre, M.
Supply Chain Risk Governance: Towards a Conceptual Multi-Level Framework
Operations and Supply Chain Management, 13(4), 382-395. Best Paper Award OSCM, 2019. (12136/0.398)
2022
-
Saïah, F., Vega, D., de Vries, H. and Kembro, J
Production and Operations Management
This exploratory research uses supply chain data analysis, qualitative content analysis, interviews, and a three-round Delphi study to investigate how Doctors without Borders (Médecins Sans Frontières; MSF) and its 151 missions employed process modularity during the Covid-19 pandemic.
-
Alban A., Blaettchen P., De Vries H., Van Wassenhove L.
Manufacturing and Service Operations Management
We present a formal model of the long-term allocation of Mobile healthcare units (MHUs) resources as the optimization of a sum of sigmoidal functions. We develop insights into optimal allocation decisions and propose pragmatic methods for estimating our model’s parameters from data available in practice. We demonstrate the potential of our approach by applying our methods to family planning MHUs in Uganda.
2021
-
Selviaridis, K. and Spring, M.
, Journal of Supply Chain Management
Consistent with the focus of the second emerging discourse incubator (EDI) on researching the effects of institutions (e.g., regulations) and public policies on supply chains, we investigate how enacted innovation policies address SME-specific institutional failures in a public sector context, that of the English National Health Service (NHS).
-
Karamshetty V., de Vries H., Van Wassenhove L., Dewilde S., Minnaard W., Ongarora D., Abuga K., Yadav P.
Production and Operations Management, 31(2).
In semi-structured interviews with managers of private healthcare facilities in Nairobi, we asked them about their (1) inventory control systems, (2) inventory control skills, (3) time/human resource constraints, (4) budget constraints, (5) motivations for inventory control, and (6) suppliers. Our results suggest that the problems are driven by resource limitations (budget and time/human resources), managerial issues (relating to skills and systems), and market mechanisms that limit overage and underage costs. Unavailability at the supplier level and motivations for inventory control are relatively minor issues.
-
de Vries H., Swinkels L., Van Wassenhove L.
Production and Operations Management, 30(12).
Using a large dataset of visits in Madagascar, Uganda, and Zimbabwe, our study models the relationship between the number of clients seen during a visit and the time since the last visit and uses this model to analyze the characteristics of optimal frequencies. We use the latter to develop simple frequency policies for practical use, prove bounds on the worst-case optimality gap, and test the impact of the policies with a simulation model.